We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer and Anumana Ink Multi-Year AI Electrocardiogram Algorithm Deal
Pfizer and Anumana Ink Multi-Year AI Electrocardiogram Algorithm Deal
Pfizer has entered into a multi-year deal with Anumana — a joint venture between the Mayo Clinic and nference, an electronic health record data company — to develop software for early detection of cardiac amyloidosis.